As AbbVie moved away from promotional spend on its aging megablockbuster Humira at the same time Sanofi and Regeneron stepped up their TV campaigns for Dupixent in 2021, you might be forgiven for ...

In 2023, AbbVie reaffirmed its ongoing trend of being the leading spender in TV drug advertising by securing both the first and second positions in pharmaceutical direct-to-consumer (DTC) spending.

AbbVie ABBV announced positive results from its mid-stage study evaluating Rinvoq (upadacitinib) in a new indication. The phase IIb study evaluated the 6 mg, 11 mg and 22 mg dose strengths of Rinvoq ...